Issue Archive
|
Subscribe
|
Editorial Board
|
About
|
Contact
|
Advertise
Home
News
Daily Nephrology News
Daily Urology News
FDA News
Malpractice News
Industry News
Newsletters
Polls & Surveys
Top 10 2008 Stories
Urology
Bladder Cancer
Benign Prostatic Hyperplasia
Erectile Dysfunction
Kidney Cancer
Kidney Stones
Overactive Bladder
Premature Ejaculation
Prostate Cancer
Prostate Specific Antigen
Reproductive Medicine
Urinary Incontinence
Urinary Tract Infections
Nephrology
Acute Kidney Injury
Acute Renal Failure
Anemia
Chronic Kidney Disease
Contrast Nephropathy
Cardiovascular Disease
Diabetes
Diabetic Nephropathy
Focal Segmental Glomerulosclerosis
Hemodialysis
Hyperphosphatemia
Hypertension
Kidney Cancer
Kidney Stones
Lupus Nephritis
Peritoneal Dialysis
Secondary Hyperparathyroidism
Transplantation
Clinical Trials
Acute Kidney Injury
Bladder Cancer
Diabetes Mellitus
Hemodialysis
Hyperphosphatemia
Kidney/Ureteral Stones
Lupus Nephritis
Nephrogenic Systemic Fibrosis
Overactive Bladder
Pelvic Prolapse
Prostate Cancer
Renal Cell Carcinoma
Renal Obstruction
Renal Transplant
Voiding Dysfunction
Commentary
Conferences
Conference Highlights
Meetings Calendar
Renal Week 2008
29th Annual Dialysis Conference
EAU Conference 2009
NKF Spring Meetings
AUA Annual Meeting
ASH Annual Meeting
American Transplant Congress 2009
Canadian Urological Association Annual Meeting
Renal Week 2009
Genitourinary Cancers Symposium
Expert Series
Jobs
Resources
Links
View Full Issue
Features
Cleveland Clinic
World Lit. Review
Legal Issues
Renal Nutrition Update
Your Money
Your Practice
Drug Info
myCME
RSS
|
Login
|
Register
Home
>
News & Features
> Industry News
Industry News
Colchicine Formulation Cleared for Preventing Gout Flares
Jody A. Charnow
November 19, 2009
Colcrys, a new colchicine formulation, has received marketing clearance for the prevention of gout flares.
Valrubicin Is Reintroduced for the Treatment of CIS
Jody A. Charnow
October 16, 2009
Endo Pharmaceuticals, of Chadds Ford, Pa., has reintroduced Valstar (valrubicin) for the treatment of carcinoma in situ (CIS) of the urinary bladder that is refractory to treatment with Bacillus-Calmette-Guérin (BCG).
Patent is Filed for Device To Ease Catheter Insertion
Jody A. Charnow
October 16, 2009
Urovalve, of Newark, N.J., has filed a patent for a device that facilitates insertion of catheters, such as Foley catheters, the company said.
Anti-CMV Drug Cleared for Pediatric Transplant Patients
Jody A. Charnow
October 16, 2009
The FDA has approved Valcyte (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant recipients (aged four months to 16 years) who are at high risk of developing the disease. FDA also approved a new pediatric oral solution formulation for the drug that will enable easier administration to these patients.
Orally Dissolving Tablets for Diabetic Gastroparesis Cleared
Jody A. Charnow
October 16, 2009
Salix Pharmaceuticals has receiving marketing clearance for Metozolv (metoclopramide HCl) ODT (orally dissolving tablets) 5 mg and 10 mg orally disintegrating tablets for the relief of diabetic gastroparesis and symptomatic documented gastroesophageal reflux (GERD).
FDA Approves Aliskiren/Valsartan Combination Pill
Jody A. Charnow
October 16, 2009
FDA has approved Valturna (aliskiren and valsartan) tablets, which the drug's maker, Novartis, of East Hanover, N.J., said is the first and only product to target two key points in the renin angiotensin aldosterone system (RAAS).
Tacrolimus Cleared for Use with MMF in Renal Transplant Patients
Jody A. Charnow
July 23, 2009
Astellas Pharma US, in Deerfield, Ill., has received approval for the use of Prograf (tacrolimus) in conjunction with mycophenolate mofetil (MMF) in kidney transplant recipients.
First and Only Topical Gel for Overactive Bladder Cleared
Jody A. Charnow
July 23, 2009
Watson Pharmaceuticals, Corona, Calif., has received approval for Gelnique (oxybutynin chloride) Gel 10%, the first and only topical gel for the treatment of overactive bladder (OAB).
Hyponatremia Drug Receives Marketing Clearance
Jody A. Charnow
July 23, 2009
The FDA has approved Samsca tablets (tolvaptan) to treat hyponatremia, one of the most common electrolyte disorders seen in hospitalized patients.
Panel Recommends Approval of Drug for Refractory Gout
July 23, 2009
The FDA's Arthritis Drugs Advisory Committee has recommended that Krystexxa (pegloticase) be approved for treating refractory chronic gout.
more »
Visit
Your Practice
for articles relating to the everyday business of nephrologists and urologists.
Editor's Pick
Renal & Urology News editor Jody Charnow shines the spotlight on one of the biggest topics affecting urology and nephrology. His most recent pick is:
Achieving Competence in RP: The Role of Experience
.
Your Money
Visit
Your Money
for the latest financial news and advice.
Our
World Literature Review
department has information on the latest nephrology and urology studies from around the world.
Visit our
Conference Highlights
section for news from recent meetings, including our coverage of the 2010 Genitourinary Cancers Symposium.
Most Popular
Most Emailed
Most Recent
Dietary Fat and Prostate Cancer Risk
Glycemic Control in Diabetic ESRD Patients
DASH Diet Variation May Help Lower Blood Pressure
Live Kidney Donation Does Not Shorten Survival
Chemo May Improve Survival in Men with Advanced PCa on ADT
A doctor referred a man with an elevated PSA level to a urologist, but did not follow-up and ask him if he went
Use of Kidneys From High-Risk Donors Drops
Clinical Trial: A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis
Clinical Trial: Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD) (SIR)
Clinical Trial: Immune System Related Kidney Disease
Drinking Alcohol Raises Prostate Cancer Risk in African Americans
Live Kidney Donation Does Not Shorten Survival
Prostate Cancer Deaths Uncommon Even 30 Years After Surgery
Dietary Fat and Prostate Cancer Risk
Hypogonadism Linked to Statin Use
Novel Drug Prolongs Survival in Men with Metastatic Prostate Cancer
Relief for Haiti's ESRD Patients
Start-Stop Hormone Therapy For Prostate Cancer May Have Benefits
DASH Diet Variation May Help Lower Blood Pressure
Urine Test Accurately Predicts Significant Prostate Cancer
Clinical Trial: Bowel Preparation and Pelvic Organ Prolapse Surgery
Clinical Trial: Pelvic Floor Repair Systems for Prolapse Repair (PROPEL)
Clinical Trial: Comparison of Burch Urethropexy and Mid-urethral Sling Performed Concomitantly With a Sacral Colpopexy
Clinical Trial: Local Anesthetic Treatments for Overactive Bladder
Clinical Trial: Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections?
Clinical Trial: Caffeine Reduction and Overactive Bladder Symptoms
Clinical Trial: Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years
Robotic Pyeloplasty Has Advantages
Clinical Trial: Nephrogenic Systemic Fibrosis (NSF): A Chart Review With Analysis of Tissue Gadolinium Levels
Clinical Trial: Immune System Related Kidney Disease
Popular Topics
Acute Kidney Injury
Adrenal Gland
Brachytherapy
Cardiovascular Disease
Chronic Kidney Disease
CKD
Diabetes
End-stage Renal Disease
FSGS
Hemodialysis
Hypertension
Infection
Kidney Cancer
Kidney Disease
Nutrition
Obesity
Prostate Cancer
Prostatitis
PSA
Renal Cell Carcinoma
Renal Masses
Transplantation
Urologic Surgery
Urology
UTI
Sponsored Links